Treatment options for Early and Metastatic Breast Cancer

This panel discussion provides an in-depth discussion on treatment options for early and metastatic breast cancer, featuring insights from experts Prof. Sotiriou and Prof. Nogueira, led by Prof. Cardoso.

Target Audience

Healthcare Professionals

Learning Objectives

  • Evaluate treatment modalities for Early Breast Cancer, including surgery, radiation, chemotherapy, and hormonal therapy, with an understanding of adjuvant and neoadjuvant strategies.
  • Assess systemic treatment options for Metastatic Breast Cancer, focusing on the role of palliative care and personalization in clinical decision-making.
  • Recognize the need for multidisciplinary efforts for optimal breast cancer management.
  • Understand the importance of available guidelines in the management of EBC and MBC.

This activity is supported by an educational grant from Eli Lilly.

Course summary

Course opens: 
02/19/2025
Course expires: 
09/30/2031
Cost:
$0.00
Rating: 
0
Dr. Christos Sotiriou

Dr. Christos Sotiriou

Research Director, Fonds de la Recherche Scientifique (FNRS)
Director, Breast Cancer Translational Research Laboratory J-C. Heuson (BCTL), Université Libre de Bruxelles (ULB)
Full Professor, Medical Oncology Department, Institut Jules Bordet (IJB)/Hôpital Universitaire de Bruxelles (HUB)
Director of the Bordet Research Laboratories (BCRL), Institut Jules Bordet (IJB)/Hôpital Universitaire de Bruxelles (HUB)

Angélica Nogueira-Rodrigues, MD, PhD

Angélica Nogueira-Rodrigues, MD, PhD

Professor and Researcher at UFMG (Federal University of Minas Gerais)

Fatima Cardoso, MD, ESCO, FESMO

Fatima Cardoso, MD, ESCO, FESMO

Fatima Cardoso, MD, FESMO, ESCO
Senior Consultant, Medical Oncology
President, Advanced Breast Cancer (ABC) Global Alliance Lisbon, Portugal

Price

Cost:
$0.00
Please login or register to take this course.